View of A review on ANDA submission requirements for Generic drugs: “Paragraph IV certification” as per FDA CDER guidelines

Return to Article Details A review on ANDA submission requirements for Generic drugs: “Paragraph IV certification” as per FDA CDER guidelines Download Download PDF